EQUITY TRUSTEES LIMITED AS RESPONSIBLE ENTITY FOR T. ROWE PRICE GLOBAL EQUITY FUND et al v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al

  1. January 12, 2018

    Valeant Sees Most Claims Against It Stick In Stock-Drop Suits

    A New Jersey federal judge on Friday refused to dismiss the bulk of claims lodged in two sets of securities suits against Valeant Pharmaceuticals International Inc., ruling, among other things, that investors' allegations of fraud and other violations met specificity requirements of the relevant laws.

  2. July 31, 2017

    T. Rowe, Funds Fight Valeant's Bid To Kill Stock Drop Suits

    T. Rowe Price Group Inc. and other investors asked a New Jersey federal court on Friday not to dismiss their securities suits against Valeant Pharmaceuticals International Inc., saying Valeant and its executives have rehashed the same arguments that the court rejected in a similar case.